HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nestlé's Novel Iron Ingredient Judged Safe For Use In Europe

Executive Summary

A new source of iron developed by Nestle has been granted a positive opinion as a novel food from the European Food Safety Authority.

You may also be interested in...

Nestlé's Iron Deficiency Supplement Among Latest EU Novel Food Authorizations

A new source of iron manufactured by Nestlé is one of four novel foods to receive authorization by the European Commission for use in dietary supplements.

New Iron Source Granted EU Novel Food Approval

Ireland's Nemysis Limited has secured authorization from the European Commission to market in the EU a novel form of iron in supplements for both adults and children.

Nestlé Expects Continued Supplement Demand Post-Pandemic

Nestlé CEO Mark Schneider says the company's consumer research indicates that the increase in dietary supplement usage over the past couple of years will endure post-pandemic. This continued demand help to lift sales at the company's Health Science business in the first half.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts